정맥 스텐트 시장 : 규모, 점유율, 성장, 산업 분석, 지역 인사이트 및 예측(2026-2034년)

Growth Factors of venous stents Market

The global venous stents market was valued at USD 1.05 billion in 2025 and is projected to grow from USD 1.13 billion in 2026 to USD 1.99 billion by 2034, registering a CAGR of 7.3% during the forecast period. Venous stents are specialized medical devices implanted in veins to restore and maintain blood flow in patients with venous obstruction, stenosis, compression disorders, deep vein thrombosis, chronic venous insufficiency, and post-thrombotic syndrome.

The market is growing steadily due to the rising prevalence of chronic venous diseases, increasing adoption of minimally invasive vascular procedures, and advancements in endovascular technologies. North America dominated the market in 2025 with a 36.19% market share.

Venous Stents Market Trends

A key trend in the market is the development of dedicated venous stent systems. Manufacturers are focusing on devices specifically designed for venous anatomy, offering better radial force, flexibility, compression resistance, long-term patency, and reduced risk of migration or restenosis. This shift is improving clinical outcomes and supporting wider adoption of endovascular venous interventions.

Market Drivers

The rising prevalence of chronic venous disorders is a major growth driver. Conditions such as deep vein thrombosis, chronic venous insufficiency, post-thrombotic syndrome, and May-Thurner syndrome can cause swelling, pain, venous obstruction, and ulcer formation. Venous stents provide durable vessel patency and improved blood flow, making them an important treatment option for long-term venous disease management.

Market Restraints

High procedure costs and limited reimbursement are major restraints. Venous stenting procedures require advanced imaging systems, specialized stent devices, skilled vascular specialists, and hospital infrastructure. In low- and middle-income countries, limited reimbursement and affordability issues restrict patient access, slowing market growth.

Market Opportunities

The expansion of endovascular treatment programs is creating strong market opportunities. Hospitals and specialty vascular centers are increasingly adopting minimally invasive procedures due to shorter hospital stays, faster recovery, and lower complication risks. Emerging markets in Asia Pacific and Latin America are also improving healthcare infrastructure, which is expected to increase access to advanced venous interventions.

Market Challenges

Limited awareness and diagnostic delays remain key challenges. In many emerging and underdeveloped countries, venous diseases are underdiagnosed due to limited access to care and shortage of trained healthcare providers. Delayed diagnosis reduces timely treatment and limits adoption of venous stenting procedures.

Segment Analysis

By stent type, the market is segmented into self-expanding venous stents, balloon-expandable venous stents, and others. The self-expanding venous stents segment accounted for the largest market share in 2025 due to superior adaptability, flexibility, and radial strength. The balloon-expandable venous stents segment is projected to grow at a CAGR of 8.7% during the forecast period.

By material, the market includes nitinol venous stents, stainless steel venous stents, and others. The nitinol venous stents segment dominated in 2025 due to its superelasticity, shape memory, corrosion resistance, and wide use by leading manufacturers. The stainless steel segment is anticipated to grow at a CAGR of 5.3%.

By application, the market is classified into chronic venous obstruction, post-thrombotic syndrome, deep vein thrombosis, May-Thurner syndrome, and others. The chronic venous obstruction segment held the largest share in 2025 and is projected to account for 36.6% share in 2026, driven by rising cases of long-standing venous blockages and compression syndromes. The post-thrombotic syndrome segment is expected to grow at a CAGR of 6.9%.

By end user, the market is segmented into hospitals & ASCs, specialty clinics, and others. Hospitals & ASCs dominated in 2025 and are expected to hold 71.9% share in 2026, supported by advanced infrastructure and specialized vascular care teams. Specialty clinics are projected to grow at a CAGR of 9.5%.

Regional Analysis

North America led the global market with USD 0.38 billion in 2025, rising from USD 0.36 billion in 2024. The U.S. market is expected to reach USD 0.36 billion in 2026, accounting for approximately 31.8% of global revenue.

Asia Pacific is projected to reach USD 0.24 billion in 2026, becoming the second-largest regional market. China is expected to reach USD 0.08 billion, Japan USD 0.05 billion, and India USD 0.04 billion in 2026.

Europe is projected to reach USD 0.32 billion in 2026, growing at 6.8% during the forecast period. The U.K. market is expected to reach USD 0.06 billion, while Germany is projected at USD 0.07 billion in 2026.

Latin America is estimated to reach USD 0.09 billion in 2026, supported by growing awareness and improving healthcare access. The GCC market is projected to reach USD 0.03 billion in 2026, representing around 2.6% of global revenues.

Competitive Landscape

The venous stents market is competitive, with major players focusing on product innovation, regulatory approvals, partnerships, and stronger distribution networks. Key companies include BD, Boston Scientific Corporation, Medtronic, Koninklijke Philips N.V., optimed Medizinische Instrumente GmbH, Cook, Bentley InnoMed GmbH, Merit Medical Systems, Sinomed, and MicroPort Scientific Corporation. Boston Scientific, Cook, and Medtronic held leading market shares in 2025 due to strong vascular intervention portfolios and wide distribution reach.

Key Industry Developments

In January 2026, W. L. Gore & Associates received FDA approval for the GORE VIABAHN FORTEGRA venous stent for deep venous disease treatment. In June 2024, Philips launched the Duo Venous Stent System after FDA premarket approval. In October 2024, Cook reported strong three-year patency results for its Zilver Vena venous self-expanding stent. In May 2022, BD's Venovo venous stent returned to the U.S. market after updated FDA clearance.

Conclusion

The global venous stents market is expected to grow from USD 1.05 billion in 2025 to USD 1.13 billion in 2026, reaching USD 1.99 billion by 2034. Growth will be driven by rising chronic venous disease prevalence, increasing demand for minimally invasive endovascular procedures, and development of dedicated venous stent systems. However, high procedure costs, limited reimbursement, and diagnostic delays may continue to challenge broader adoption.

Segmentation By Stent Type, Material, Application, End-user, and Region

By Stent Type * Self-Expanding Venous Stents

• Balloon-Expandable Venous Stents
• Others

By Material * Nitinol Venous Stents

• Stainless Steel Venous Stents
• Others

By Application * Chronic Venous Obstruction

• Post-Thrombotic Syndrome
• Deep Vein Thrombosis (DVT)
• May-Thurner Syndrome
• Others

By End-user * Hospitals & ASCs

• Specialty Clinics
• Others

By Region * North America (By Stent Type, Material, Application, End-user, and Country)

• U.S. (By Stent Type)
• Canada (By Stent Type)
• Europe (By Stent Type, Material, Application, End-user, and Country/Sub-region)
  • Germany (By Stent Type)
  • U.K. (By Stent Type)
  • France (By Stent Type)
  • Spain (By Stent Type)
  • Italy (By Stent Type)
  • Scandinavia (By Stent Type)
  • Rest of Europe (By Stent Type)
• Asia Pacific (By Stent Type, Material, Application, End-user, and Country/Sub-region)
  • China ( By Stent Type)
  • Japan ( By Stent Type)
  • India ( By Stent Type)
  • Australia ( By Stent Type)
  • Southeast Asia ( By Stent Type)
  • Rest of Asia Pacific ( By Stent Type)
• Latin America (By Size, Procedure, End-user and Country/Sub-region)
  • Brazil ( By Stent Type)
  • Mexico ( By Stent Type)
  • Rest of Latin America ( By Stent Type)
• Middle East & Africa (By Stent Type, Material, Application, End-user, and Country/Sub-region)
  • GCC ( By Stent Type)
  • South Africa ( By Stent Type)
  • Rest of the Middle East & Africa ( By Stent Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Conditions, by key Country/Region, 2025
• 4.2. Advancements in Venous Stents
• 4.3. Key Industry Developments - (Mergers, Acquisitions & Partnerships, etc.)

5. Global Venous Stents Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Stent Type
  • 5.1.1. Self-Expanding Venous Stents
  • 5.1.2. Balloon-Expandable Venous Stents
  • 5.1.3. Others
• 5.2. Market Analysis, Insights and Forecast - By Material
  • 5.2.1. Nitinol Venous Stents
  • 5.2.2. Stainless Steel Venous Stents
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Chronic Venous Obstruction
  • 5.3.2. Post-Thrombotic Syndrome
  • 5.3.3. Deep Vein Thrombosis (DVT)
  • 5.3.4. May-Thurner Syndrome
  • 5.3.5. Others
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Hospitals & ASCs
  • 5.4.2. Specialty Clinics
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Venous Stents Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Stent Type
  • 6.1.1. Self-Expanding Venous Stents
  • 6.1.2. Balloon-Expandable Venous Stents
  • 6.1.3. Others
• 6.2. Market Analysis, Insights and Forecast - By Material
  • 6.2.1. Nitinol Venous Stents
  • 6.2.2. Stainless Steel Venous Stents
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Chronic Venous Obstruction
  • 6.3.2. Post-Thrombotic Syndrome
  • 6.3.3. Deep Vein Thrombosis (DVT)
  • 6.3.4. May-Thurner Syndrome
  • 6.3.5. Others
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Hospitals & ASCs
  • 6.4.2. Specialty Clinics
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. By Stent Type
  • 6.5.2. Canada
    • 6.5.2.1. By Stent Type

7. Europe Venous Stents Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Stent Type
  • 7.1.1. Self-Expanding Venous Stents
  • 7.1.2. Balloon-Expandable Venous Stents
  • 7.1.3. Others
• 7.2. Market Analysis, Insights and Forecast - By Material
  • 7.2.1. Nitinol Venous Stents
  • 7.2.2. Stainless Steel Venous Stents
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Chronic Venous Obstruction
  • 7.3.2. Post-Thrombotic Syndrome
  • 7.3.3. Deep Vein Thrombosis (DVT)
  • 7.3.4. May-Thurner Syndrome
  • 7.3.5. Others
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Hospitals & ASCs
  • 7.4.2. Specialty Clinics
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.5.1. Germany
    • 7.5.1.1. By Stent Type
  • 7.5.2. U.K.
    • 7.5.2.1. By Stent Type
  • 7.5.3. France
    • 7.5.3.1. By Stent Type
  • 7.5.4. Italy
    • 7.5.4.1. By Stent Type
  • 7.5.5. Spain
    • 7.5.5.1. By Stent Type
  • 7.5.6. Scandinavia
    • 7.5.6.1. By Stent Type
  • 7.5.7. Rest of Europe
    • 7.5.7.1. By Stent Type

8. Asia Pacific Venous Stents Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Stent Type
  • 8.1.1. Self-Expanding Venous Stents
  • 8.1.2. Balloon-Expandable Venous Stents
  • 8.1.3. Others
• 8.2. Market Analysis, Insights and Forecast - By Material
  • 8.2.1. Nitinol Venous Stents
  • 8.2.2. Stainless Steel Venous Stents
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Chronic Venous Obstruction
  • 8.3.2. Post-Thrombotic Syndrome
  • 8.3.3. Deep Vein Thrombosis (DVT)
  • 8.3.4. May-Thurner Syndrome
  • 8.3.5. Others
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Hospitals & ASCs
  • 8.4.2. Specialty Clinics
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.5.1. China
    • 8.5.1.1. By Stent Type
  • 8.5.2. India
    • 8.5.2.1. By Stent Type
  • 8.5.3. Japan
    • 8.5.3.1. By Stent Type
  • 8.5.4. Australia
    • 8.5.4.1. By Stent Type
  • 8.5.5. Southeast Asia
    • 8.5.5.1. By Stent Type
  • 8.5.6. Rest of Asia Pacific
    • 8.5.6.1. By Stent Type

9. Latin America Venous Stents Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Stent Type
  • 9.1.1. Self-Expanding Venous Stents
  • 9.1.2. Balloon-Expandable Venous Stents
  • 9.1.3. Others
• 9.2. Market Analysis, Insights and Forecast - By Material
  • 9.2.1. Nitinol Venous Stents
  • 9.2.2. Stainless Steel Venous Stents
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Chronic Venous Obstruction
  • 9.3.2. Post-Thrombotic Syndrome
  • 9.3.3. Deep Vein Thrombosis (DVT)
  • 9.3.4. May-Thurner Syndrome
  • 9.3.5. Others
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Hospitals & ASCs
  • 9.4.2. Specialty Clinics
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.5.1. Brazil
    • 9.5.1.1. By Stent Type
  • 9.5.2. Mexico
    • 9.5.2.1. By Stent Type
  • 9.5.3. Rest of Latin America
    • 9.5.3.1. By Stent Type

10. Middle East & Africa Venous Stents Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Stent Type
  • 10.1.1. Self-Expanding Venous Stents
  • 10.1.2. Balloon-Expandable Venous Stents
  • 10.1.3. Others
• 10.2. Market Analysis, Insights and Forecast - By Material
  • 10.2.1. Nitinol Venous Stents
  • 10.2.2. Stainless Steel Venous Stents
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Chronic Venous Obstruction
  • 10.3.2. Post-Thrombotic Syndrome
  • 10.3.3. Deep Vein Thrombosis (DVT)
  • 10.3.4. May-Thurner Syndrome
  • 10.3.5. Others
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Hospitals & ASCs
  • 10.4.2. Specialty Clinics
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.5.1. South Africa
    • 10.5.1.1. By Stent Type
  • 10.5.2. GCC
    • 10.5.2.1. By Stent Type
  • 10.5.3. Rest of Middle East & Africa
    • 10.5.3.1. By Stent Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. BD
  • 11.2.2. Boston Scientific Corporation
  • 11.2.3. Medtronic
  • 11.2.4. Koninklijke Philips N.V.
  • 11.2.5. optimed Medizinische Instrumente GmbH
  • 11.2.6. Cook
  • 11.2.7. Bentley InnoMed GmbH
  • 11.2.8. Merit Medical Systems
  • 11.2.9. Sinomed
  • 11.2.10. MicroPort Scientific Corporation